Vertex Reviews Corporate Strategy and Outlines Key 2014 Business Priorities at …

Published January 14, 2014

Vertex Reviews Corporate Strategy and Outlines Key 2014 Business Priorities at …
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today outlined key 2014 business priorities aimed at supporting investment in future opportunities in cystic fibrosis (CF) and other high-potential research and development programs. … President and …
Read more on Wall Street Journal

Acorda Therapeutics Provides Corporate Update at 32nd Annual J.P. Morgan …
President and CEO Ron Cohen, M.D. will provide a corporate overview today at the 32nd Annual J.P. Morgan Healthcare Conference at 11:00 a.m. Pacific Time in San Francisco. … Tablets, 10 mg, a treatment to improve walking in patients with multiple …
Read more on MarketWatch

Harsh US Drug Laws To Change, Says Eric Holder — “With the U.S. facing massive overcrowding in its prisons, Attorney General Eric Holder called Monday for major changes to the nation’s criminal justice syst…

More Drug Treatment Programs In San Francisco Information…